Skip to content

EPO Medical: what changed

BE 0797.807.578Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€14,149
2024 · €27,023-€41,172
Equity
€110,402
2024 · €124,551-€14,149
Cash
-
not filed
Balance sheet total
€114,418
2024 · €166,377-€51,959

Largest movements

2024 to 2025
Assets
  • Deferred charges and accrued income -€59,443

    down €59,443 (-94.0%), from €63,243 to €3,800

  • Current investments +€10,573

    up €10,573 (+11.5%), from €91,555 to €102,129

  • Tangible fixed assets -€7,010

    down €7,010 (-62.0%), from €11,298 to €4,288

  • Receivables within one year +€3,921

    up €3,921 (+1,400%), from €280 to €4,201

Equity and liabilities
  • Tax, wage and social debts -€37,975

    down €37,975 (-99.6%), from €38,135 to €161

  • Profit (loss) carried forward -€14,149

    down €14,149 (-14.7%), from €96,031 to €81,882

Income statement
  • Gross operating margin -€50,358

    down €50,358, from €46,759 to -€3,599

  • Taxes -€11,223

    down €11,223 (-98.6%), from €11,384 to €161

  • Financial charges +€1,531

    up €1,531 (+377%), from €406 to €1,937

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €27,023
Gross operating margin -€50,358
Depreciation -€463
Other operating charges -€22
Financial income -€21
Financial charges -€1,531
Taxes +€11,223
Result 2025 -€14,149
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Cash or the result is not a separate line in both sets of accounts. So the cash flow cannot be derived from them.

Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €166,377 €114,418 -€51,959 -31.2%
Fixed assets 21/28 €11,298 €4,288 -€7,010 -62.0%
Tangible fixed assets 22/27 €11,298 €4,288 -€7,010 -62.0%
Furniture and vehicles 24 €11,298 €4,288 -€7,010 -62.0%
Current assets 29/58 €155,078 €110,129 -€44,949 -29.0%
Amounts receivable within one year 40/41 €280 €4,201 +€3,921 +1,400%
Trade receivables 40 €280 €4,201 +€3,921 +1,400%
Current investments 50/53 €91,555 €102,129 +€10,573 +11.5%
Deferred charges and accrued income 490/1 €63,243 €3,800 -€59,443 -94.0%
Total equity and liabilities 10/49 €166,377 €114,418 -€51,959 -31.2%
Equity 10/15 €124,551 €110,402 -€14,149 -11.4%
Contributions 10/11 €1,500 €1,500 = 0.0%
Reserves 13 €27,020 €27,020 = 0.0%
Distributable reserves 133 €27,020 €27,020 = 0.0%
Profit (loss) carried forward 14 €96,031 €81,882 -€14,149 -14.7%
Amounts payable 17/49 €41,826 €4,015 -€37,810 -90.4%
Amounts payable within one year 42/48 €41,826 €4,015 -€37,810 -90.4%
Trade debts 44 €436 €1,113 +€676 +155%
Suppliers 440/4 €436 €1,113 +€676 +155%
Taxes, remuneration and social security 45 €38,135 €161 -€37,975 -99.6%
Taxes 450/3 €38,135 €161 -€37,975 -99.6%
Other amounts payable 47/48 €3,254 €2,742 -€512 -15.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €7,294 €7,757 +€463 +6.3%
Other operating charges 640/8 €673 €695 +€22 +3.3%
Gross operating margin 9900 €46,759 -€3,599 -€50,358
Operating profit (loss) 9901 €38,792 -€12,051 -€50,843
Financial income 75/76B €21 - -€21
Recurring financial income 75 €21 - -€21
Financial charges 65/66B €406 €1,937 +€1,531 +377%
Recurring financial charges 65 €406 €1,937 +€1,531 +377%
Profit (loss) for the period before taxes 9903 €38,407 -€13,988 -€52,395
Income taxes 67/77 €11,384 €161 -€11,223 -98.6%
Profit (loss) for the period 9904 €27,023 -€14,149 -€41,172
Profit (loss) for the period to be appropriated 9905 €27,023 -€14,149 -€41,172

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€184,848 to €236,706

Midpoint €206,455 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €110,402
Capitalised earnings €259,293 to €363,010
Indication €184,848 to €236,706

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€110,402
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€110,402

Capitalised earnings

net result for the year (9904)
2025
-€14,149
2024
€27,023
2023
€96,028
Average result
€36,301
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€259,293 / €302,508 / €363,010

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.